يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Read, RC"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

    المؤلفون: Liu, X, Munro, APS, Wright, A, Feng, S, Janani, L, Aley, PK, Babbage, G, Baker, J, Baxter, D, Bawa, T, Bula, M, Cathie, K, Chatterjee, K, Dodd, K, Enever, Y, Fox, L, Qureshi, E, Goodman, AL, Green, CA, Haughney, J, Hicks, A, Jones, CE, Kanji, N, Van der Klaauw, AA, Libri, V, Llewelyn, MJ, Mansfield, R, Maallah, M, McGregor, AC, Minassian, AM, Moore, P, Mughal, M, Mujadidi, YF, Belhadef, HT, Holliday, K, Osanlou, O, Osanlou, R, Owens, DR, Pacurar, M, Palfreeman, A, Pan, D, Rampling, T, Regan, K, Saich, S, Saralaya, D, Sharma, S, Sheridan, R, Stokes, M, Thomson, EC, Todd, S, Twelves, C, Read, RC, Charlton, S, Hallis, B, Ramsay, M, Andrews, N, Lambe, T, Nguyen-Van-Tam, JS, Cornelius, V, Snape, MD, Faust, SN, COV-BOOST study group

    المصدر: 26 ; 18

    جغرافية الموضوع: England

    العلاقة: Journal of Infection; http://hdl.handle.net/10044/1/103918Test

    الإتاحة: https://doi.org/10.1016/j.jinf.2023.04.012Test
    http://hdl.handle.net/10044/1/103918Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial

    المؤلفون: Liu, X, Munro, APS, Feng, S, Janani, L, Aley, PK, Babbage, G, Baxter, D, Bula, M, Cathie, K, Chatterjee, K, Dejnirattisai, W, Dodd, K, Enever, Y, Qureshi, E, Goodman, AL, Green, CA, Harndahl, L, Haughney, J, Hicks, A, Van der Klaauw, AA, Kwok, J, Libri, V, Llewelyn, MJ, McGregor, AC, Minassian, AM, Moore, P, Mughal, M, Mujadidi, YF, Holliday, K, Osanlou, O, Osanlou, R, Owens, DR, Pacurar, M, Palfreeman, A, Pan, D, Rampling, T, Regan, K, Saich, S, Serafimova, T, Saralaya, D, Screaton, GR, Sharma, S, Sheridan, R, Sturdy, A, Supasa, P, Thomson, EC, Todd, S, Twelves, C, Read, RC, Charlton, S, Hallis, B, Ramsay, M, Andrews, N, Lambe, T, Nguyen-Van-Tam, JS, Cornelius, V, Snape, MD, Faust, SN, COV-BOOST study group

    المصدر: 813 ; 795

    مصطلحات موضوعية: COVID-19 vaccine, Fractional dose, Heterologous boost, Homologous boost, Immunogenicity, Persistence, Third dose, Ad26COVS1, Adult, Aged, 80 and over, Antibodies, Viral, BNT162 Vaccine, COVID-19, COVID-19 Vaccines, ChAdOx1 nCoV-19, Humans, Vaccine, Immunoglobulin G, Middle Aged, SARS-CoV-2, United Kingdom, Viral Vaccines, mRNA Vaccines, COV-BOOST study group

    جغرافية الموضوع: England

    العلاقة: Journal of Infection; http://hdl.handle.net/10044/1/97555Test

    الإتاحة: https://doi.org/10.1016/j.jinf.2022.04.018Test
    http://hdl.handle.net/10044/1/97555Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

    المؤلفون: Shaw, RH, Liu, X, Stuart, ASV, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Dejnirattisai, W, Dinesh, T, Faust, SN, Ferreira, DM, Finn, A, Green, CA, Hallis, B, Heath, PT, Hill, H, Lambe, T, Lazarus, R, Libri, V, Long, F, Mujadidi, YF, Plested, EL, Morey, ER, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, Walker, LL, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV Study Group

    المساهمون: National Institute for Health and Care Research

    مصطلحات موضوعية: Com-COV Study Group, 1103 Clinical Sciences, 1117 Public Health and Health Services, 1199 Other Medical and Health Sciences

    جغرافية الموضوع: England

    العلاقة: The Lancet Respiratory Medicine; http://hdl.handle.net/10044/1/97462Test; PR-R17-0916-22001/-02/-03/-04

    الإتاحة: https://doi.org/10.1016/S2213-2600Test(22)00163-1
    http://hdl.handle.net/10044/1/97462Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

    المؤلفون: Munro, APS, Janani, L, Cornelius, V, Aley, PK, Babbage, G, Baxter, D, Bula, M, Cathie, K, Chatterjee, K, Dodd, K, Enever, Y, Gokani, K, Goodman, AL, Green, CA, Harndahl, L, Haughney, J, Hicks, A, Van der Klaauw, AA, Kwok, J, Libri, V, Llewelyn, MJ, McGregor, AC, Minassian, AM, Moore, P, Mughal, M, Mujadidi, YF, Murira, J, Osanlou, O, Osanlou, R, Owens, DR, Pacurar, M, Palfreeman, A, Pan, D, Rampling, T, Regan, K, Saich, S, Salkeld, J, Saralaya, D, Sharma, S, Sheridan, R, Sturdy, A, Thomson, EC, Todd, S, Twelves, C, Read, RC, Charlton, S, Hallis, B, Ramsay, M, Andrews, N, Nguyen-Van-Tam, JS, Snape, MD, Liu, X, Faust, SN, COV-BOOST study group

    مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, Adult, Aged, 80 and over, BNT162 Vaccine, COVID-19, ChAdOx1 nCoV-19, Female, Humans, Immunization, Secondary, Immunogenicity, Vaccine, Male, Middle Aged, Pandemics, Patient Safety, SARS-CoV-2, United Kingdom, COV-BOOST study group, 11 Medical and Health Sciences

    جغرافية الموضوع: England

    العلاقة: The Lancet; http://hdl.handle.net/10044/1/93014Test

    الإتاحة: https://doi.org/10.1016/S0140-6736Test(21)02717-3
    http://hdl.handle.net/10044/1/93014Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    المؤلفون: Liu, X, Shaw, RH, Stuart, ASV, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Dinesh, T, England, A, Faust, SN, Ferreira, DM, Finn, A, Green, CA, Hallis, B, Heath, PT, Hill, H, Lambe, T, Lazarus, R, Libri, V, Long, F, Mujadidi, YF, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Singh, N, Turner, DPJ, Turner, PJ, Walker, LL, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV Study Group

    المساهمون: Department of Health

    المصدر: 869 ; 856

    مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, REACTOGENICITY, EFFICACY, Com-COV Study Group, Humans, Immunoglobulin G, Antibodies, Viral, Immunization Schedule, Single-Blind Method, Aged, Middle Aged, Female, Male, Intention to Treat Analysis, Spike Glycoprotein, Coronavirus, Immunogenicity, Vaccine, Equivalence Trials as Topic, COVID-19, COVID-19 Vaccines, 11 Medical and Health Sciences

    جغرافية الموضوع: England

    العلاقة: The Lancet; http://hdl.handle.net/10044/1/91019Test; 039/0031

    الإتاحة: https://doi.org/10.1016/S0140-6736Test(21)01694-9
    http://hdl.handle.net/10044/1/91019Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

    المؤلفون: Stuart, ASV, Shaw, RH, Liu, X, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Darton, T, Dinesh, T, Duncan, CJA, England, A, Faust, SN, Ferreira, DM, Finn, A, Goodman, AL, Green, CA, Hallis, B, Heath, PT, Hill, H, Horsington, BM, Lambe, T, Lazarus, R, Libri, V, Lillie, PJ, Mujadidi, YF, Payne, R, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV2 Study Group

    المصدر: 49 ; 36

    مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, Com-COV2 Study Group, 11 Medical and Health Sciences

    جغرافية الموضوع: England

    العلاقة: The Lancet; http://hdl.handle.net/10044/1/93015Test

    الإتاحة: https://doi.org/10.1016/S0140-6736Test(21)02718-5
    http://hdl.handle.net/10044/1/93015Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث